These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26417350)

  • 1. pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugs.
    Tila D; Yazdani-Arazi SN; Ghanbarzadeh S; Arami S; Pourmoazzen Z
    EXCLI J; 2015; 14():21-32. PubMed ID: 26417350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma stable, pH-sensitive non-ionic surfactant vesicles simultaneously enhance antiproliferative effect and selectivity of Sirolimus.
    Ghanbarzadeh S; Khorrami A; Pourmoazzen Z; Arami S
    Pharm Dev Technol; 2015 May; 20(3):279-87. PubMed ID: 24266760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone.
    Ghanbarzadeh S; Arami S; Pourmoazzen Z; Ghasemian-Yadegari J; Khorrami A
    J Biomater Appl; 2014 Jul; 29(1):81-92. PubMed ID: 24336315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the antiproliferative effect of rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes.
    Ghanbarzadeh S; Arami S; Pourmoazzen Z; Khorrami A
    Colloids Surf B Biointerfaces; 2014 Mar; 115():323-30. PubMed ID: 24394948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of pH-sensitive polymer/niosome complexes.
    Francis MF; Dhara G; Winnik FM; Leroux JC
    Biomacromolecules; 2001; 2(3):741-9. PubMed ID: 11710027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs.
    Roux E; Francis M; Winnik FM; Leroux JC
    Int J Pharm; 2002 Aug; 242(1-2):25-36. PubMed ID: 12176222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low cytotoxic elastic niosomes loaded with salmon calcitonin on human skin fibroblasts.
    Manosroi A; Chankhampan C; Ofoghi H; Manosroi W; Manosroi J
    Hum Exp Toxicol; 2013 Jan; 32(1):31-44. PubMed ID: 23111885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis Induction, Cell Cycle Arrest and Anti-Cancer Potential of Tamoxifen-Curcumin Loaded Niosomes Against MCF-7 Cancer Cells.
    Fatemizadeh M; Tafvizi F; Shamsi F; Amiri S; Farajzadeh A; Akbarzadeh I
    Iran J Pathol; 2022; 17(2):183-190. PubMed ID: 35463725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.
    Khan DH; Bashir S; Correia A; Khan MI; Figueiredo P; Santos HA; Peltonen L
    Int J Pharm; 2019 Dec; 572():118764. PubMed ID: 31628977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.
    Wang M; Yuan Y; Gao Y; Ma HM; Xu HT; Zhang XN; Pan WS
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1134-41. PubMed ID: 22182601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
    Akbarzadeh I; Farid M; Javidfar M; Zabet N; Shokoohian B; Arki MK; Shpichka A; Noorbazargan H; Aghdaei HA; Hossein-Khannazer N; Timashev P; Makvandi P; Vosough M
    AAPS PharmSciTech; 2022 Jan; 23(1):57. PubMed ID: 35048234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes.
    Taymouri S; Varshosaz J
    Adv Biomed Res; 2016; 5():48. PubMed ID: 27110545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes.
    Arunothayanun P; Turton JA; Uchegbu IF; Florence AT
    J Pharm Sci; 1999 Jan; 88(1):34-8. PubMed ID: 9874699
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hajizadeh MR; Maleki H; Barani M; Fahmidehkar MA; Mahmoodi M; Torkzadeh-Mahani M
    Res Pharm Sci; 2019 Oct; 14(5):448-458. PubMed ID: 31798662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes.
    Shaker DS; Shaker MA; Hanafy MS
    Int J Pharm; 2015 Sep; 493(1-2):285-94. PubMed ID: 26200748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.
    Ghanbarzadeh S; Khorrami A; Mohamed Khosroshahi L; Arami S
    Pharm Biol; 2014 Jul; 52(7):848-54. PubMed ID: 24920230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin-conjugated pluronic niosomes as a new drug delivery system for anticancer therapy.
    Tavano L; Muzzalupo R; Mauro L; Pellegrino M; Andò S; Picci N
    Langmuir; 2013 Oct; 29(41):12638-46. PubMed ID: 24040748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeling of Preformed Niosomes with [
    Almasi A; Shahhosseini S; Haeri A; Daha FJ; Geramifar P; Dadashzadeh S
    AAPS PharmSciTech; 2018 Nov; 19(8):3859-3870. PubMed ID: 30291544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.